What the three-part evidence-gathering method includes and how it helps to achieve both patient- & public health benefit and long-term economic success.
Akceso’s ‘Evidence-based Asset Valuation’ methodology Read More »
Read the thoughts of András Incze related to the Advanced High-Performance Leadership (HPL) program led by Professor George Kohlrieser.
How a hostage negotiator can inspire business leaders? Read More »
This 5 years of research explores how external reference pricing (ERP, or also called as IRP – International Reference Pricing) is used to set pharmaceutical prices to improve affordability, but how its application may have negative consequences on patient access across certain countries.
We are happy to share with you the blog post of András Incze, CEO of Akceso Advisors on what was accomplished, how we made an impact with our international team in these challenging times and lived up again to our promise.
We Look Back To A Remarkable Year 2021 Read More »
4 good reasons of running marathon: Read thoughts of András Incze about how marathon running became a passionate habit for him and how it reflects in Akceso.
The Essence of 17 Years in Marathon Running Read More »
“I am really pleased with the outcome…. and seldom agree so quickly with
Great Feedback For Our Recent Pricing & Reimbursement Project Read More »
The US Government just published its “Comprehensive Plan for Addressing High Drug Prices”. It lists a number of initiatives and ideas, but does NOT mention is International Reference Pricing – and this is good news for patients in the US and worldwide (and for manufacturers, too). – Read the Akceso Advisors reflection on a latest development in the US pharmaceuticals market based on Akceso Advisors’ research related to the impact of International Reference Pricing (IRP) on patient access and innovation.
Akceso Advisors AG
Aeschengraben 29.
CH-4051 Basel, Switzerland
Verity IRP Master Tool
Verity Analogues Wizard
Verity Prices & Reimbursements
Verity MarketScout Rules & Regulations
Verity Managed Entry Agreements
Verity Tender Management
Verity Approvals
PRiMA Headlines
© 2011-2024 Akceso Advisors AG | Photos by Luca Gőbölyös & Thomas Bittera
Get in touch with us and schedule a demo.
Error: Contact form not found.
The PRiMA Headlines Newsletter provides a monthly overview of developments in Pricing, Reimbursement and Market Access across the globe. Since its launch in June 2015 we have covered more than 8,000 stories from over 160 countries.
